Skip to main content
HRES 449 104th Congress House Health Artificial implants Autoimmune diseases Breast cancer Commerce Education Educational policy Government Operations and Politics Government paperwork Health education Joint diseases Product safety Women Women's health

Relating to breast implants, the Food and Drug Administration, and breast care.

Introduced: June 6, 1996 See on congress.gov
Sign in to write a letter Sign in to watch
This resolution expired with the 104th Congress
It was not agreed to before the 104th Congress (1995–1996) adjourned, so it is no longer active. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 4 steps
Introduced
In committee
Reported out
Agreed to (House)
Jun 14, 1996
Referred to the Subcommittee on Health and Environment.
Jun 7, 1996
Sponsor introductory remarks on measure. (CR E1032-1033)
Jun 6, 1996
Referred to the House Committee on Commerce.
Jun 6, 1996
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Expresses the sense of the House of Representatives that: (1) the Food and Drug Administration should issue a definitive statement on the relationship (or lack thereof) between silicone gel breast implants and connective tissue disease, classic auto-immune symptoms, and other serious diseases; and (2) the Food and Drug Administration and the National Cancer Institute should develop recommendations for breast care for women with breast implants.

What's happening now June 14, 1996

Referred to the Subcommittee on Health and Environment.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 2
 Cosponsors 1
All 1 Republican 1
R
Calvert, Ken
California · Jun 6, 1996
Cite this page click to expand
APA
U.S. Congress. (2026). H. Res. 449: Relating to breast implants, the Food and Drug Administration, and breast care.. 104th Congress. Open America. https://openamerica.io/bill/104-HRES-449/
MLA
"H. Res. 449: Relating to breast implants, the Food and Drug Administration, and breast care.." 104th Congress, 2026, Open America, https://openamerica.io/bill/104-HRES-449/.
Bluebook (legal)
H. Res. 449, 104th Cong. (2026), https://openamerica.io/bill/104-HRES-449/.
Markdown link
[H. Res. 449: Relating to breast implants, the Food and Drug Administration, and breast care.](https://openamerica.io/bill/104-HRES-449/)
Report a problem